Skip to search formSkip to main contentSkip to account menu

R-2323

Known as: R 2323, R2323 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

GestrinoneProgestational Hormones, Synthetic
Nemestran

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Luteolytic effect of the antiprogestin and antiglucocorticoid agent RU486 in rats.
1988
1988
Induction of estradiol dehydrogenase activity in human uterine endometrium by synthetic steroids
The effects of P and six synthetic steroids (MPA, ENT, CAP, R2323, DL and EEL) on estradiol dehydrogenase (E2DH) activity were… 
1986
1986
Gestrinone (R2323) Binding to Steroid Receptors in Human Uterine Endometrial Cytosol
To understand the mechanism of biological action of gestrinone (R2323), which has a therapeutic effect against endometriosis, the… 
1982
1982
Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone.
Highly Cited
1978
Highly Cited
1978
Steroid release from silastic capsules and rods.
1978
1978
Mechanism of antiprogestational action of synthetic steroids.
The mechanism of antiprogestational effect of the synthetic steroid was studied in relation to the progesterone (P) receptor in… 
1978
1978
Clinical chemistry in women treated with progestogen implants.
1974
1974
Inhibition of spermatogenesis.
The effect upon spermatogenesis of subdermal silastic capsules containing testosterone in combination with various oral drugs was… 
1974
1974
Effect of a once weekly oral contraceptive upon gonadotrophin and gonadal steroid levels.
1972
1972
Aspects on the mode of action of antiestrogens and antiprogestogens.
Most so-called antiestrogens are ‘estrogenic’ in the mouse uterine growth test and in the Allen-Doisy test (in mice or rats… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)